US pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to NGOs seeking to protect vulnerable people from illness in humanitarian crises.
In what it called a major expansion of its humanitarian assistance work, the drugmaker said its Prevenar 13 shot, which protects children against pneumonia and other diseases, would be offered in a new multi-dose vial at the lowest prevailing global price, currently $3.10 per dose.
“Pfizer will donate all sales proceeds for the first year of this program to humanitarian groups undertaking the difficult work of reaching vulnerable populations in emergency settings,” the company said in a statement.
The move follows a similar one by the British drugmaker GlaxoSmithKline, which said in September it would cut the price of its pneumococcal vaccine, Synflorix, to $3.05 when it is used in humanitarian crises.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.